Pay in 4 interest-free payments of $7.20 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Typical dosage (oral or subQ): 250500mcg 12x daily Administration: Oral capsules or subcutaneous injection Cycle length: 46 weeks depending on severity In studies on rats with induced ulcerative colitis, BPC-157 preserved gut lining integrity and improved inflammatory markers. Drmic, D
GHK-Cu has an extensive safety record in topical applications and is well-tolerated in injectable protocols at appropriate doses
Levels naturally decline with age, stress, poor diet, and toxin exposure, which may impact skin health, immunity, and cellular aging
It encourages the production of pheomelanin (lighter pigment) over eumelanin (darker pigment)
New blood vessel growth serves healing purposes, but uncontrolled angiogenesis has implications for conditions involving abnormal vascular proliferation
